The value of semiquantitative analysis in identifying diffuse bone marrow involvement in follicular lymphoma

被引:16
作者
El-Najjar, Inas [1 ]
Montoto, Silvia [1 ]
McDowell, Amy [2 ]
Matthews, Janet [1 ]
Gribben, John [1 ]
Szyszko, Teresa A. [2 ,3 ]
机构
[1] Kings Coll London, St Thomas Hosp, Ctr Haematooncol, London SE1 7EH, England
[2] Kings Coll London, St Thomas Hosp, Dept Nucl Med, Ctr Mol Oncol,Barts Canc Inst, London SE1 7EH, England
[3] Kings Coll London, Div Imaging Sci & Biomed Engn, Clin PET Ctr, St Thomas Hosp, London SE1 7EH, England
基金
英国医学研究理事会; 英国工程与自然科学研究理事会;
关键词
bone marrow biopsy; diffuse bone marrow; F-18-FDG-PET; follicular lymphoma; prognosis; POSITRON-EMISSION-TOMOGRAPHY; HODGKIN-LYMPHOMA; F-18-FDG PET; FDG-PET; INFILTRATION; MANAGEMENT; IMPACT;
D O I
10.1097/MNM.0000000000000059
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AimThe aim of the study was to investigate the value of fluorine-18-fluorodeoxyglucose (F-18-FDG)-PET/computed tomography (CT) in identifying diffuse bone marrow (BM) involvement in follicular lymphoma using semiquantitative assessment.MethodsThis is a retrospective analysis of 41 patients with grade 1-3a follicular lymphoma who underwent F-18-FDG-PET/CT, contrast-enhanced CT and bone marrow trephine biopsy (BMB) as part of staging. BM involvement on PET/CT was assessed by visual and semiquantitative analysis. Standardized uptake values (SUVmax) were measured at the sternum, at both iliac blades and at the T-12 vertebra. An average of these four measurements was recorded as SUVav. The single highest overall SUVmax for the four bone sites, the SUVav and the ratios SUVav/mediastinal blood pool (MBP) and SUVav/liver were compared with the BMB result.ResultsFocal bone uptake was identified on F-18-FDG-PET/CT by visual analysis in six patients, including two cases in which the BMB was negative. Assessment of diffuse BM involvement on F-18-FDG-PET/CT by visual analysis had a sensitivity and specificity of 31 and 92%, respectively. Semiquantitative analysis resulted in an improved sensitivity and specificity of 58 and 96%, respectively, when using SUVav greater than or equal to 2 as the cutoff. Using the ratio SUVav/MBP greater than or equal to 1 the sensitivity of F-18-FDG-PET/CT to detect BM involvement improved to 83%.ConclusionVisual analysis is useful in determining focal bone involvement, whereas semiquantitative analysis using SUVav/MBP has a high sensitivity and specificity for predicting BM involvement in patients lacking focal bone lesions. (C) 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码:311 / 315
页数:5
相关论文
共 26 条
[1]   Radionuclide imaging of bone marrow disorders [J].
Agool, Ali ;
Glaudemans, Andor W. J. M. ;
Boersma, Hendrikus H. ;
Dierckx, Rudi A. J. O. ;
Vellenga, Edo ;
Slart, Riemer H. J. A. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (01) :166-178
[2]  
Bain BJ, 2006, HAEMATOLOGICA, V91, P1293
[3]   Imaging Follicular Lymphoma Using Positron Emission Tomography With [18F]Fluorodeoxyglucose: To What Purpose? [J].
Barrington, Sally F. ;
Mikhaeel, N. George .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (35) :4285-4287
[4]   Detection of lymphoma in bone marrow by whole-body positron emission tomography [J].
Carr, R ;
Barrington, SF ;
Madan, B ;
O'Doherty, MJ ;
Saunders, CAB ;
van der Walt, J ;
Timothy, AR .
BLOOD, 1998, 91 (09) :3340-3346
[5]   SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma [J].
Casasnovas, Rene -Olivier ;
Meignan, Michel ;
Berriolo-Riedinger, Alina ;
Bardet, Stephane ;
Julian, Anne ;
Thieblemont, Catherine ;
Vera, Pierre ;
Bologna, Serge ;
Briere, Josette ;
Jais, Jean-Philippe ;
Haioun, Corinne ;
Coiffier, Bertrand ;
Morschhauser, Franck .
BLOOD, 2011, 118 (01) :37-43
[6]   F-18 FDG PET for Evaluation of Bone Marrow Involvement in Non-Hodgkin Lymphoma A Meta-analysis [J].
Chen, Yen-Kung ;
Yeh, Chia-Lu ;
Tsui, Chih-Cheng ;
Liang, Ji-An ;
Chen, Jin-Hua ;
Kao, Chia-Hung .
CLINICAL NUCLEAR MEDICINE, 2011, 36 (07) :553-559
[7]   Hodgkin Lymphoma: Protecting the Victims of Our Success [J].
Cheson, Bruce D. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (36) :4456-4457
[8]  
Cortes-Romera M, 2013, CLIN NUCL MED
[9]   Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Dreyling, M. .
ANNALS OF ONCOLOGY, 2010, 21 :v181-v183
[10]   Utility of FDG-PET scanning in lymphoma by WHO classification [J].
Elstrom, R ;
Guan, L ;
Baker, G ;
Nakhoda, K ;
Vergilio, JA ;
Zhuang, H ;
Pitsilos, S ;
Bagg, A ;
Downs, L ;
Mehrotra, A ;
Kim, S ;
Alavi, A ;
Schuster, SJ .
BLOOD, 2003, 101 (10) :3875-3876